Search — EtoBox

7 works shown

Showing the first matches. Checking the full catalogue…

Books

Small Loans,big Dreams How Nobel Prize Winner Muhammad Yunus and Microfinance Are Changing the World,alex Counts,john Wiley & Sons

Counts, Alex & 2 more

2008PDF18 MB

Cinderella / Alex and the Glass Slipper

Amanda Graham, Jane O'Loughlin, Susan Hill

1991PDF4.4 MB

Small and medium-sized enterprises

John Forth

2006

Practical Radio Servicing; a Simplified Approach to the Servicing of A-C/D-C Superheterodyne Receivers, Battery Receivers, Three-way Portables, and Small Phonograph Combinations William Marcus Alex Levy.

William. Marcus

1955

Documents

Alex Small

Sriram GovindaRaj

Small Stories Michael - and - Alex

precious lara

Certificate of Non-Remarriage Form

alextirkey050505

Research articles

Alex Gough, Differential Diagnosis in Small Animal Medicine , Blackwell Publishing, Ames/Oxford (2007) ISBN 1405132523 464 pages

Shell · Journal of Feline Medicine and Surgery

2008PDF65 KB

Small Loans, Big Dreams: How the Nobel Prize Winner Muhammad Yunus and Microfinance are Changing the World, edited by Alex Counts

Gebremariam · Eastern Economic Journal

2010PDF66 KB

Final Progression-free Survival Results from the J-ALEX Study of Alectinib Versus Crizotinib in ALK-positive Non-small-cell Lung Cancer

Nakagawa · Lung Cancer

2019PDF1.7 MB

J-ALEX Trial Will Crown Alectinib as the Standard Choice for Anaplastic Lymphoma Kinase Positive Untreated Non-small Cell Lung Cancer Patients?

Gridelli · AME Publishing Company

2018PDF134 KB

Alectinib Versus Crizotinib in Patients with ALK -positive Non-small-cell Lung Cancer (J-ALEX): an Open-label, Randomised Phase 3 Trial

Hida · The Lancet

2017PDF681 KB

The Upward Spiral: Using Neuroscience to Reverse the Course of Depression, One Small Change at a Time, by Alex Korb

Kindle · Social Work in Mental Health

2017PDF356 KB

Analysis of Central Nervous System Efficacy in the J-ALEX Study of Alectinib Versus Crizotinib in ALK-positive Non-small-cell Lung Cancer

Nishio · Lung Cancer

2018PDF233 KB

Alectinib Versus Crizotinib in Treatment-naive Anaplastic Lymphoma Kinase-positive (ALK+) Non-small-cell Lung Cancer: CNS Efficacy Results from the ALEX Study

Gadgeel · Annals of Oncology

2018PDF932 KB

MA07.03 Alectinib (ALC) versus Crizotinib (CRZ) in ALK-Positive Non-Small Cell Lung Cancer (ALK+ NSCLC): Primary Results from Phase III Study (J-ALEX)

Kim · Journal of Thoracic Oncology

2017PDF197 KB

138PD_PR Patient-reported Outcomes (PROs) in ALEX: A Phase III Study of Alectinib (ALEC) vs Crizotinib (CRIZ) in Non-small-cell Lung Cancer (NSCLC)

Perol · Journal of Thoracic Oncology

2018PDF98 KB

Patient-reported Outcomes from the Randomized Phase III ALEX Study of Alectinib Versus Crizotinib in Patients with ALK-positive Non-small-cell Lung Cancer

Pérol · Lung Cancer

2019PDF2.2 MB

410O_PRAlectinib (ALC) vs crizotinib (CRZ) in treatment-naïve ALK+ non-small-cell lung cancer (NSCLC): Asian vs non-Asian subgroup analysis of the ALEX study

Mok · Annals of Oncology

2017PDF72 KB